Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 1999 Mar 19

PMID 10081672

Citations 34

Authors

L Zeitlin

R A Cone

K J Whaley

Affiliations

Soon will be listed here.

Abstract

Passive immunization with antibodies has been shown to prevent a wide variety of diseases. Recent advances in monoclonal antibody technology are enabling the development of new methods for passive immunization of mucosal surfaces. Human monoclonal antibodies, produced rapidly, inexpensively, and in large quantities, may help prevent respiratory, diarrheal, and sexually transmitted diseases on a public health scale.

Citing Articles

Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody.

Abelson D, Barajas J, Stuart L, Kim D, Marimuthu A, Hu C J Infect Dis. 2023; 228(Suppl 7):S701-S711.

PMID: 37474248 PMC: 11009508. DOI: 10.1093/infdis/jiad278.

Clinical Aspects of B Cell Immunodeficiencies: The Past, the Present and the Future.

Ahmed A, Lippner E, Khanolkar A Cells. 2022; 11(21).

PMID: 36359748 PMC: 9654110. DOI: 10.3390/cells11213353.

A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters.

Chaturvedi S, Beutler N, Vasen G, Pablo M, Chen X, Calia G Proc Natl Acad Sci U S A. 2022; 119(39):e2204624119.

PMID: 36074824 PMC: 9522362. DOI: 10.1073/pnas.2204624119.

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.

Phelps A, OBrien L, Ulaeto D, Holtsberg F, Liao G, Douglas R Viruses. 2021; 13(11).

PMID: 34835037 PMC: 8621548. DOI: 10.3390/v13112231.

Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception.

Shrestha B, Vincent K, Schaefer A, Zhu Y, Vargas G, Motamedi M Proc Natl Acad Sci U S A. 2021; 118(48).

PMID: 34815336 PMC: 8640842. DOI: 10.1073/pnas.2107832118.

References

Tsume Y, Taki Y, Sakane T, NADAI T, Sezaki H, Watabe K . Quantitative evaluation of the gastrointestinal absorption of protein into the blood and lymph circulation. Biol Pharm Bull. 1996; 19(10):1332-7. DOI: 10.1248/bpb.19.1332. View

Adamus G, MULCZYK M, Witkowska D, Romanowska E . Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp. Infect Immun. 1980; 30(2):321-4. PMC: 551312. DOI: 10.1128/iai.30.2.321-324.1980. View

Nussbaum G, Yuan R, Casadevall A, Scharff M . Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans. J Exp Med. 1996; 183(4):1905-9. PMC: 2192512. DOI: 10.1084/jem.183.4.1905. View

Vaughan T, Williams A, Pritchard K, Osbourn J, Pope A, Earnshaw J . Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol. 1996; 14(3):309-14. DOI: 10.1038/nbt0396-309. View

Sherry B, Li X, Tyler K, Cullen J, Virgin 4th H . Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol. 1993; 67(10):6119-24. PMC: 238034. DOI: 10.1128/JVI.67.10.6119-6124.1993. View

Davidson G, Whyte P, Daniels E, Franklin K, Nunan H, McCloud P . Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet. 1989; 2(8665):709-12. DOI: 10.1016/s0140-6736(89)90771-x. View

Lamm M . Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol. 1997; 51:311-40. DOI: 10.1146/annurev.micro.51.1.311. View

Apter F, Michetti P, Winner 3rd L, Mack J, Mekalanos J, Neutra M . Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun. 1993; 61(12):5279-85. PMC: 281312. DOI: 10.1128/iai.61.12.5279-5285.1993. View

Tacket C, Binion S, Bostwick E, Losonsky G, Roy M, Edelman R . Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg. 1992; 47(3):276-83. DOI: 10.4269/ajtmh.1992.47.276. View

10.

Harmon R, RUTHERFORD R, Wu H, Collins M . Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection. Infect Immun. 1989; 57(7):1936-41. PMC: 313823. DOI: 10.1128/iai.57.7.1936-1941.1989. View

11.

Zeitlin L, Whaley K, Sanna P, Moench T, Bastidas R, De Logu A . Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2. Virology. 1996; 225(1):213-5. DOI: 10.1006/viro.1996.0589. View

12.

Kraehenbuhl J, Neutra M . Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev. 1992; 72(4):853-79. DOI: 10.1152/physrev.1992.72.4.853. View

13.

Hiatt A . Antibodies produced in plants. Nature. 1990; 344(6265):469-70. DOI: 10.1038/344469a0. View

14.

Prince G, Hemming V, Horswood R, Baron P, Chanock R . Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol. 1987; 61(6):1851-4. PMC: 254189. DOI: 10.1128/JVI.61.6.1851-1854.1987. View

15.

Booth V, Ashley F, Lehner T . Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect Immun. 1996; 64(2):422-7. PMC: 173780. DOI: 10.1128/iai.64.2.422-427.1996. View

16.

Mo H, Stamatatos L, Ip J, Barbas C, Parren P, Burton D . Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off. J Virol. 1997; 71(9):6869-74. PMC: 191968. DOI: 10.1128/JVI.71.9.6869-6874.1997. View

17.

Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

18.

Johnson A, McDonald P, Neoh S . Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis. J Protozool. 1983; 30(2):351-6. DOI: 10.1111/j.1550-7408.1983.tb02929.x. View

19.

Saltzman W . Antibodies for treating and preventing disease: the potential role of polymeric controlled release. Crit Rev Ther Drug Carrier Syst. 1993; 10(2):111-42. View

20.

Eis-Hubinger A, Schmidt D, SCHNEWEIS K . Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J Gen Virol. 1993; 74 ( Pt 3):379-85. DOI: 10.1099/0022-1317-74-3-379. View